Anti-HIV Jab To Be Available in South Africa by 2024, but Netizens Want Cure

Anti-HIV Jab To Be Available in South Africa by 2024, but Netizens Want Cure

  • A drug which might cancel one’s chances of getting HIV through intercourse might be available in South Africa by 2024
  • This is according to Mitchell Warren, who works with the AIDS Vaccine Advocacy Coalition to make the product available
  • Netizens were upset that the drug, named CAB-LA, is not a cure, which is what they believe the nation needs

Tebogo Mokwena, a dedicated current affairs journalist, contributed coverage of social issues in South Africa during his seven years at Daily Sun and Vutivi Business News.

South Africa will be one of the few nations in Africa that will receive an anti-HIV drug
Netizens do not want an anti-HIV drug but a cure. Image: Luke Dray/Getty Images
Source: Getty Images

South Africans are not satisfied that the country might receive an anti-HIV jab in the next two years to curb the spread of HIV in the country. Mitchell Warren of the AIDS Vaccine Advocacy Coalition recently announced that the country will be one of the few globally to receive the product. Netizens questioned why, instead of anti-HIV medication, there isn’t a cure.

Read also

Parliament to debate closing Israel’s embassy, South Africans disinterested

Anti-HIV drug to be tested in SA

According to TimesLIVE, the drug, called CAB-LA, is expected to be made available in small batches by 2024. These will be administered bi-monthly during trials. The drug is expected to remove a person’s chances of getting HIV through sexual intercourse. Warren clarified that these would not be clinical trials but studies to determine how the product would be implemented.

Warren, who was interviewed on a podcast by the Bhekisisa Centre for Health Journalism, added that the studies would begin next year, as South Africa is on the list of nations to receive the drug.

South Africa is ranked the country with the highest HIV infection rate, as millions in the country are on antiretrovirals (ARV) to manage HIV, including celebrities who live with the disease.

Read also

Pravin Gordhan suggests private sector partnerships with SOEs, SA feels betrayed: “It was his plan”

South Africans prefer the cure

Netizens on Facebook are dissatisfied with an anti-HIV drug and wanted a cure.

Walktall Elelwani Brynos pointed out:

“I don’t think they can’t find a cure.”

Kaya Rwai Rwai said:

“These laboratories must just give people the cure for HIV. They may want to make money first.”

Chris Eksteen responded:

“They must find a cure, but they would rather prevent it. This is South Africa.”

Others were against it.

Thozamile Gift Qobo said:

“We’re not gonna get tired of warning our people. Please don’t take these things. No person can feed you a poison and give you a cure for the poison he fed you.”

GabotseMpitseng Phzti Costa Lamola wrote:

“I wonder who will be the volunteers in such nonsense.”

Maskandi artist gets tested for HIV in public

In a similar article, Briefly News reported that Maskandi artist Khuzani Mpungose did an HIV test in public.

Read also

2 Killed outside Randburg Magistrates Court, leaving SA horrified by brutal murder

He explained that he did the test to educate his followers and fans on the importance of getting tested regularly. He also added that he ensures he gets tested three times a month.

PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ click on “Recommended for you” and enjoy!

Source: Briefly News

Authors:
Tebogo Mokwena avatar

Tebogo Mokwena (Current Affairs editor) Tebogo Mokwena is a Current Affairs Editor at Briefly News. He has a Diploma in Journalism from ALISON. He joined Daily Sun, where he worked for 4 years covering politics, crime, entertainment, current affairs, policy, governance and art. He was also a sub-editor and journalist for Capricorn Post before joining Vutivi Business News in 2020, where he covered small business news policy and governance, analysis and profiles. He joined Briefly News in 2023. Tebogo passed a set of trainings by Google News Initiative Email: tebogo.mokwena@briefly.co.za

Tags: